Rupert Handgretinger

5PUBLICATIONS
36CO-AUTHORS
Surface water quality processes and contaminated sediment assessmentCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersTumour immunologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 29, 2025
Double Filtration Plasmapheresis for Environmental Toxin Removal: A Case Series of Patients With Hyperlipoproteinemia(a).

Yandy Marx Castillo-Aleman, Carlos Agustin Villegas-Valverde, Maysoon Al-Karam

|Jan 11, 2025
Long-Term Outcomes and Quality of Life of High-Risk Neuroblastoma Patients Treated with a Multimodal Treatment Including Anti-GD2 Immunotherapy: A Retrospective Cohort Study.

Tim Flaadt, Jonas Rehm, Thorsten Simon

|Nov 09, 2024
Ecto-NOX Disulfide-Thiol Exchanger 2 (ENOX2/tNOX) Is a Potential Prognostic Marker in Primary Malignant Melanoma and May Serve as a Therapeutic Target.

Matti Böcker, Eftychia Chatziioannou, Heike Niessner

|Aug 23, 2023
Th1 cytokines in pediatric acute lymphoblastic leukemia.

Sarah Schober, Jennifer M Rottenberger, Johannes Hilz

|Feb 28, 2023
Anti-GD2 Antibody Dinutuximab Beta and Low-Dose Interleukin 2 After Haploidentical Stem-Cell Transplantation in Patients With Relapsed Neuroblastoma: A Multicenter, Phase I/II Trial.

Tim Flaadt, Ruth L Ladenstein, Martin Ebinger

Pageof 1

Frequent Collaborators

2 joint publications

Tim Flaadt

2 joint publications

Peter Lang

2 joint publications

Holger N Lode

2 joint publications

Martin Ebinger